Medicare Enrolled

Dr. Ania Janicka, D.O.

Endocrinology · Hudson, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
14100 FIVAY RD, Hudson, FL 34667
7278697822
In practice since 2007 (18 years)
NPI: 1538353305 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Janicka from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Janicka? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Janicka

Dr. Ania Janicka is an endocrinology in Hudson, FL, with 18 years in practice. Based on federal Medicare data, Dr. Janicka performed 4,036 Medicare services across 1,091 unique beneficiaries.

Between the years covered by Open Payments, Dr. Janicka received a total of $340,111 from 64 pharmaceutical and/or device companies across 1244 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Janicka is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 15% volume in FL$ $340,111 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,036
Medicare services
Top 15% in FL for endocrinology
1,091
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~224 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)2,280$19$30
Office visit, established patient (30-39 min)440$93$214
Blood glucose (sugar) test performed by hand-held instrument407$3$9
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report269$26$86
Office visit, established patient, complex (40-54 min)234$131$286
Ultrasound scan of head and neck soft tissue101$78$244
Office visit, established patient (20-29 min)99$60$146
Drug injection, under skin or into muscle63$11$51
New patient office visit (45-59 min)51$116$333
Hospital follow-up visit, low complexity34$40$78
New patient office visit, complex (60-74 min)22$149$412
Diabetes outpatient self-management training services, individual, per 30 minutes22$41$105
Fine needle aspiration biopsy using ultrasound guidance, first growth14$108$282
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$340,111
Total received (2018-2024)
Avg $48,587/year across 7 years
Top 3% in FL for endocrinology
64
Companies
1,244
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$325,968 (95.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,143 (4.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$52,538
2023
$40,008
2022
$82,488
2021
$43,552
2020
$47,834
2019
$44,928
2018
$28,763

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$195,464
Merck Sharp & Dohme Corporation
$39,964
Insulet Corporation
$34,347
Dexcom, Inc.
$33,288
Amryt Pharma Holdings Ltd
$9,259
Chiesi USA, Inc.
$4,896
Abbott Laboratories
$3,881
Valeritas, Inc.
$3,350
Zealand Pharma US, Inc.
$2,015
DEXCOM, INC.
$1,939
Lilly USA, LLC
$1,478
SANOFI-AVENTIS U.S. LLC
$1,165
Amgen Inc.
$1,097
Corcept Therapeutics
$962
AstraZeneca Pharmaceuticals LP
$615
Xeris Pharmaceuticals, Inc.
$492
Amarin Pharma Inc.
$412
Tandem Diabetes Care, Inc.
$403
Janssen Pharmaceuticals, Inc
$311
Medtronic MiniMed, Inc.
$297
Amneal Pharmaceuticals LLC
$280
MannKind Corporation
$270
Bayer HealthCare Pharmaceuticals Inc.
$262
Bayer Healthcare Pharmaceuticals Inc.
$244
Mannkind Corporation
$232
Radius Health, Inc.
$209
RECORDATI_RARE_DISEASES_INC.
$196
Boehringer Ingelheim Pharmaceuticals, Inc.
$189
Kyowa Kirin, Inc.
$180
Medtronic, Inc.
$170
ABBVIE INC.
$165
Shire North American Group Inc
$164
Nevro Corp.
$162
IBSA Pharma Inc.
$154
Merck Sharp & Dohme LLC
$145
Esperion Therapeutics, Inc.
$143
BETA BIONICS, INC.
$134
Companion Medical, Inc.
$130
Kowa Pharmaceuticals America, Inc.
$92
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$82
Horizon Therapeutics plc
$76
LifeScan, Inc.
$75
PFIZER INC.
$70
EUSA Pharma (US) LLC
$69
Ipsen Biopharmaceuticals, Inc
$56
OPKO Pharmaceuticals, LLC
$53
Astellas Pharma US Inc
$43
AbbVie Inc.
$41
CeQur Corporation
$40
LIFESCAN, INC.
$40
AbbVie, Inc.
$35
Ultragenyx Pharmaceutical Inc.
$32
Lexicon Pharmaceuticals, Inc.
$31
Ferring Pharmaceuticals Inc.
$29
Novartis Pharmaceuticals Corporation
$28
Neurocrine Biosciences, Inc.
$26
Roche Diabetes Care, Inc.
$22
VIVUS, Inc.
$19
Gemini Laboratories, LLC
$18
Azurity Pharmaceuticals, Inc.
$16
Orexigen Therapeutics, Inc.
$15
Alnylam Pharmaceuticals Inc.
$15
VIVUS LLC
$14
Strongbridge US INC.
$12
Top 3 companies account for 79.3% of total payments
Associated products mentioned in payments ›
AFREZZA · Adthyza · BAQSIMI · BYDUREON · CONTRAVE · CREON · CYCLOSET · Cables · CeQur Simplicity · Crysvita · DC ACCU-CHEK Diabetes Management Solutions · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Freedom Lite system · FreeStyle Libre · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GIVLAARI · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · KEVEYIS · Kerendia · Kits and Accessories · Korlym · LEQVIO · LICART · LOKELMA · LYUMJEV · Livalo · MACRILEN · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · Norditropin · OT Verio Flex Starter Kit · Omnia · Omnipod · OneTouch · Ozempic · Prolia · QSYMIA · RAYALDEE · RECORLEV · RYBELSUS · Rayaldee · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STEGLUJAN · SYNTHROID · Saxenda · Senza · Software · Somatuline Depot · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Veozah · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · ZOMACTON · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for endocrinology in FL.

Equivalent to $8,427 per 100 Medicare services performed
Looking for a endocrinology in Hudson?
Compare endocrinologys in the Hudson area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
26
Per 100K population
4.4
County median income
$67,384
Nearest hospital
HCA FLORIDA BAYONET POINT HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Janicka is a clinical cardiology specialist, with above-average Medicare volume (top 15% in FL), and high industry engagement (speaking/promotional, top 3%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Janicka experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Janicka performed 2,280 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Janicka receive payments from pharmaceutical companies?
Yes. Dr. Janicka received a total of $340,111 from 64 companies across 1,244 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Janicka's costs compare to other endocrinologys in Hudson?
Dr. Janicka's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Janicka) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →